Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 274 entries
Sorted by: Best Match Show Resources per page
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer.

Journal of bone oncology

Edwards CM, Clements ME, Vecchi LA, Johnson JA, Johnson RW.
PMID: 34934614
J Bone Oncol. 2021 Dec 01;31:100407. doi: 10.1016/j.jbo.2021.100407. eCollection 2021 Dec.

Breast cancer cells frequently disseminate to the bone marrow, where they either induce osteolysis or enter a dormant state. Downregulation of leukemia inhibitory factor receptor (LIFR), a known breast tumor suppressor, enables otherwise dormant MCF7 human breast cancer cells...

Cite
Edwards CM, Clements ME, Vecchi LA, et al. HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer. J Bone Oncol. 2021;31:100407doi: 10.1016/j.jbo.2021.100407.
Edwards, C. M., Clements, M. E., Vecchi, L. A., Johnson, J. A., & Johnson, R. W. (2021). HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer. Journal of bone oncology, 31100407. https://doi.org/10.1016/j.jbo.2021.100407
Edwards, Courtney M, et al. "HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer." Journal of bone oncology vol. 31 (2021): 100407. doi: https://doi.org/10.1016/j.jbo.2021.100407
Edwards CM, Clements ME, Vecchi LA, Johnson JA, Johnson RW. HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer. J Bone Oncol. 2021 Dec 01;31:100407. doi: 10.1016/j.jbo.2021.100407. eCollection 2021 Dec. PMID: 34934614; PMCID: PMC8661052.
Copy Download .nbib Format: NLM
Perceived Discrimination Among Surgical Residents at Academic Medical Centers.

The Journal of surgical research

Khubchandani JA, Atkinson RB, Ortega G, Reidy E, Mullen JT, Smink DS.
PMID: 34942508
J Surg Res. 2021 Dec 20;272:79-87. doi: 10.1016/j.jss.2021.10.029. Epub 2021 Dec 20.

BACKGROUND: Residents of color experience microaggressions in the work environment, are less likely to feel that they fit into their training programs, and feel less comfortable asking for help. Discrimination has been documented among surgical residents, but has not...

Cite
Khubchandani JA, Atkinson RB, Ortega G, et al. Perceived Discrimination Among Surgical Residents at Academic Medical Centers. J Surg Res. 2021;272:79-87doi: 10.1016/j.jss.2021.10.029.
Khubchandani, J. A., Atkinson, R. B., Ortega, G., Reidy, E., Mullen, J. T., Smink, D. S. (2021). Perceived Discrimination Among Surgical Residents at Academic Medical Centers. The Journal of surgical research, 27279-87. https://doi.org/10.1016/j.jss.2021.10.029
Khubchandani, Jasmine A, et al. "Perceived Discrimination Among Surgical Residents at Academic Medical Centers." The Journal of surgical research vol. 272 (2021): 79-87. doi: https://doi.org/10.1016/j.jss.2021.10.029
Khubchandani JA, Atkinson RB, Ortega G, Reidy E, Mullen JT, Smink DS. Perceived Discrimination Among Surgical Residents at Academic Medical Centers. J Surg Res. 2021 Dec 20;272:79-87. doi: 10.1016/j.jss.2021.10.029. Epub 2021 Dec 20. PMID: 34942508.
Copy Download .nbib Format: NLM
Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes.

Transplantation direct

D'Costa MR, Merzkani MA, Denic A, Mullan AF, Larson JJ, Kremers WK, Park WD, Alexander MP, Chakkera HA, Taler SJ, Erickson SJ, Stegall MD, Issa N, Rule AD.
PMID: 34966845
Transplant Direct. 2021 Dec 23;8(1):e1278. doi: 10.1097/TXD.0000000000001278. eCollection 2022 Jan.

BACKGROUND: Nephrolithiasis in living kidney donors is concerning due to the potential impact on long-term postdonation kidney function.METHODS: We performed a cohort study of living kidney donors from 2 centers with a baseline computed tomography scan and implantation renal...

Cite
D'Costa MR, Merzkani MA, Denic A, et al. Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes. Transplant Direct. 2021;8(1):e1278doi: 10.1097/TXD.0000000000001278.
D'Costa, M. R., Merzkani, M. A., Denic, A., Mullan, A. F., Larson, J. J., Kremers, W. K., Park, W. D., Alexander, M. P., Chakkera, H. A., Taler, S. J., Erickson, S. J., Stegall, M. D., Issa, N., & Rule, A. D. (2022). Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes. Transplantation direct, 8(1), e1278. https://doi.org/10.1097/TXD.0000000000001278
D'Costa, Matthew R, et al. "Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes." Transplantation direct vol. 8,1 (2022): e1278. doi: https://doi.org/10.1097/TXD.0000000000001278
D'Costa MR, Merzkani MA, Denic A, Mullan AF, Larson JJ, Kremers WK, Park WD, Alexander MP, Chakkera HA, Taler SJ, Erickson SJ, Stegall MD, Issa N, Rule AD. Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes. Transplant Direct. 2021 Dec 23;8(1):e1278. doi: 10.1097/TXD.0000000000001278. eCollection 2022 Jan. PMID: 34966845; PMCID: PMC8710319.
Copy Download .nbib Format: NLM
Co-stimulatory and co-inhibitory immune markers in solid tumors with .

Future science OA

Reckamp KL, McQuerry JA, Mambetsariev I, Pharaon R, Yost SE, Fricke J, Mirzapoiazova T, Pillai RK, Khan Z, Fakih M, Yuan Y, Koczywas M, Massarelli E, Kulkarni P, Pal SK, Sattler M, Bild A, Salgia R.
PMID: 33437521
Future Sci OA. 2020 Nov 25;7(2):FSO662. doi: 10.2144/fsoa-2020-0159.

The implication of

Cite
Reckamp KL, McQuerry JA, Mambetsariev I, et al. Co-stimulatory and co-inhibitory immune markers in solid tumors with . Future Sci OA. 2020;7(2):FSO662doi: 10.2144/fsoa-2020-0159.
Reckamp, K. L., McQuerry, J. A., Mambetsariev, I., Pharaon, R., Yost, S. E., Fricke, J., Mirzapoiazova, T., Pillai, R. K., Khan, Z., Fakih, M., Yuan, Y., Koczywas, M., Massarelli, E., Kulkarni, P., Pal, S. K., Sattler, M., Bild, A., & Salgia, R. (2020). Co-stimulatory and co-inhibitory immune markers in solid tumors with . Future science OA, 7(2), FSO662. https://doi.org/10.2144/fsoa-2020-0159
Reckamp, Karen L, et al. "Co-stimulatory and co-inhibitory immune markers in solid tumors with ." Future science OA vol. 7,2 (2020): FSO662. doi: https://doi.org/10.2144/fsoa-2020-0159
Reckamp KL, McQuerry JA, Mambetsariev I, Pharaon R, Yost SE, Fricke J, Mirzapoiazova T, Pillai RK, Khan Z, Fakih M, Yuan Y, Koczywas M, Massarelli E, Kulkarni P, Pal SK, Sattler M, Bild A, Salgia R. Co-stimulatory and co-inhibitory immune markers in solid tumors with . Future Sci OA. 2020 Nov 25;7(2):FSO662. doi: 10.2144/fsoa-2020-0159. PMID: 33437521; PMCID: PMC7787173.
Copy Download .nbib Format: NLM
Hearing Impairment in Infants with Hypoxic Ischemic Encephalopathy Treated with Hypothermia.

Therapeutic hypothermia and temperature management

Michniewicz B, Wroblewska-Seniuk K, Amara JA, Al-Saad SR, Szyfter W, Karbowski LM, Gadzinowski J, Szymankiewicz M, Szpecht D.
PMID: 33512300
Ther Hypothermia Temp Manag. 2021 Jan 28; doi: 10.1089/ther.2020.0043. Epub 2021 Jan 28.

Therapeutic hypothermia acts as the standard of care for infants with moderate to severe hypoxic ischemic encephalopathy (HIE). A proportion of neonates who undergo hypothermia due to HIE have shown to develop various degrees of hearing impairment. Analyzing and...

Cite
Michniewicz B, Wroblewska-Seniuk K, Amara JA, et al. Hearing Impairment in Infants with Hypoxic Ischemic Encephalopathy Treated with Hypothermia. Ther Hypothermia Temp Manag. 2021;doi: 10.1089/ther.2020.0043.
Michniewicz, B., Wroblewska-Seniuk, K., Amara, J. A., Al-Saad, S. R., Szyfter, W., Karbowski, L. M., Gadzinowski, J., Szymankiewicz, M., & Szpecht, D. (2021). Hearing Impairment in Infants with Hypoxic Ischemic Encephalopathy Treated with Hypothermia. Therapeutic hypothermia and temperature management, . https://doi.org/10.1089/ther.2020.0043
Michniewicz, Barbara, et al. "Hearing Impairment in Infants with Hypoxic Ischemic Encephalopathy Treated with Hypothermia." Therapeutic hypothermia and temperature management vol. (2021). doi: https://doi.org/10.1089/ther.2020.0043
Michniewicz B, Wroblewska-Seniuk K, Amara JA, Al-Saad SR, Szyfter W, Karbowski LM, Gadzinowski J, Szymankiewicz M, Szpecht D. Hearing Impairment in Infants with Hypoxic Ischemic Encephalopathy Treated with Hypothermia. Ther Hypothermia Temp Manag. 2021 Jan 28; doi: 10.1089/ther.2020.0043. Epub 2021 Jan 28. PMID: 33512300.
Copy Download .nbib Format: NLM
Tc-99m sulfur colloid SPECT-CT in diagnosis of Splenogonadal Fusion.

Journal of nuclear medicine technology

Daghas FA, Asiri JA, Hassine H, Aamry AI.
PMID: 34750231
J Nucl Med Technol. 2021 Nov 08; doi: 10.2967/jnmt.121.262233. Epub 2021 Nov 08.

The type of accessory spleens that associate with the gonad called Splenogonadal fusion (SGF). A 3 years old boy was referring to King Saud Medical City by his parent with a left scrotal swelling that was noticed since one...

Cite
Daghas FA, Asiri JA, Hassine H, et al. Tc-99m sulfur colloid SPECT-CT in diagnosis of Splenogonadal Fusion. J Nucl Med Technol. 2021;doi: 10.2967/jnmt.121.262233.
Daghas, F. A., Asiri, J. A., Hassine, H., & Aamry, A. I. (2021). Tc-99m sulfur colloid SPECT-CT in diagnosis of Splenogonadal Fusion. Journal of nuclear medicine technology, . https://doi.org/10.2967/jnmt.121.262233
Daghas, Fatimah Ahmed, et al. "Tc-99m sulfur colloid SPECT-CT in diagnosis of Splenogonadal Fusion." Journal of nuclear medicine technology vol. (2021). doi: https://doi.org/10.2967/jnmt.121.262233
Daghas FA, Asiri JA, Hassine H, Aamry AI. Tc-99m sulfur colloid SPECT-CT in diagnosis of Splenogonadal Fusion. J Nucl Med Technol. 2021 Nov 08; doi: 10.2967/jnmt.121.262233. Epub 2021 Nov 08. PMID: 34750231.
Copy Download .nbib Format: NLM
A Role for Yeast/Pseudohyphal Cells of .

Frontiers in microbiology

Roselletti E, Monari C, Sabbatini S, Perito S, Vecchiarelli A, Sobel JD, Cassone A.
PMID: 31803172
Front Microbiol. 2019 Nov 15;10:2669. doi: 10.3389/fmicb.2019.02669. eCollection 2019.

In acute vulvovaginal candidiasis (VVC), the fungus

Cite
Roselletti E, Monari C, Sabbatini S, et al. A Role for Yeast/Pseudohyphal Cells of . Front Microbiol. 2019;10:2669doi: 10.3389/fmicb.2019.02669.
Roselletti, E., Monari, C., Sabbatini, S., Perito, S., Vecchiarelli, A., Sobel, J. D., & Cassone, A. (2019). A Role for Yeast/Pseudohyphal Cells of . Frontiers in microbiology, 102669. https://doi.org/10.3389/fmicb.2019.02669
Roselletti, Elena, et al. "A Role for Yeast/Pseudohyphal Cells of ." Frontiers in microbiology vol. 10 (2019): 2669. doi: https://doi.org/10.3389/fmicb.2019.02669
Roselletti E, Monari C, Sabbatini S, Perito S, Vecchiarelli A, Sobel JD, Cassone A. A Role for Yeast/Pseudohyphal Cells of . Front Microbiol. 2019 Nov 15;10:2669. doi: 10.3389/fmicb.2019.02669. eCollection 2019. PMID: 31803172; PMCID: PMC6873873.
Copy Download .nbib Format: NLM
Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells.

Cell reports. Medicine

Reighard SD, Cranert SA, Rangel KM, Ali A, Gyurova IE, de la Cruz-Lynch AT, Tuazon JA, Khodoun MV, Kottyan LC, Smith DF, Brunner HI, Waggoner SN.
PMID: 33205070
Cell Rep Med. 2020 Aug 25;1(5):100080. doi: 10.1016/j.xcrm.2020.100080. eCollection 2020 Aug 25.

[This corrects the article DOI: 10.1016/j.xcrm.2020.100003.].

Cite
Reighard SD, Cranert SA, Rangel KM, et al. Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. Cell Rep Med. 2020;1(5):100080doi: 10.1016/j.xcrm.2020.100080.
Reighard, S. D., Cranert, S. A., Rangel, K. M., Ali, A., Gyurova, I. E., de la Cruz-Lynch, A. T., Tuazon, J. A., Khodoun, M. V., Kottyan, L. C., Smith, D. F., Brunner, H. I., & Waggoner, S. N. (2020). Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. Cell reports. Medicine, 1(5), 100080. https://doi.org/10.1016/j.xcrm.2020.100080
Reighard, Seth D, et al. "Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells." Cell reports. Medicine vol. 1,5 (2020): 100080. doi: https://doi.org/10.1016/j.xcrm.2020.100080
Reighard SD, Cranert SA, Rangel KM, Ali A, Gyurova IE, de la Cruz-Lynch AT, Tuazon JA, Khodoun MV, Kottyan LC, Smith DF, Brunner HI, Waggoner SN. Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. Cell Rep Med. 2020 Aug 25;1(5):100080. doi: 10.1016/j.xcrm.2020.100080. eCollection 2020 Aug 25. PMID: 33205070; PMCID: PMC7659506.
Copy Download .nbib Format: NLM
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.

Gynecologic oncology

Basaran D, Boerner T, Suhner J, Sassine D, Liu Y, Grisham RN, Tew WP, Gardner GJ, Zivanovic O, Sonoda Y, Long Roche K, Chi DS, Abu-Rustum NR, Soff GA, Jewell EL.
PMID: 34312001
Gynecol Oncol. 2021 Oct;163(1):36-40. doi: 10.1016/j.ygyno.2021.07.030. Epub 2021 Jul 24.

PURPOSE: To determine the incidence of venous thromboembolism (VTE) and define clinical risk factors associated with the development of new-onset VTE in patients receiving neoadjuvant chemotherapy (NACT) for ovarian cancer (OC).METHODS: An institutional ovarian cancer database was used to...

Cite
Basaran D, Boerner T, Suhner J, et al. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Gynecol Oncol. 2021;163(1):36-40doi: 10.1016/j.ygyno.2021.07.030.
Basaran, D., Boerner, T., Suhner, J., Sassine, D., Liu, Y., Grisham, R. N., Tew, W. P., Gardner, G. J., Zivanovic, O., Sonoda, Y., Long Roche, K., Chi, D. S., Abu-Rustum, N. R., Soff, G. A., & Jewell, E. L. (2021). Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Gynecologic oncology, 163(1), 36-40. https://doi.org/10.1016/j.ygyno.2021.07.030
Basaran, Derman, et al. "Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy." Gynecologic oncology vol. 163,1 (2021): 36-40. doi: https://doi.org/10.1016/j.ygyno.2021.07.030
Basaran D, Boerner T, Suhner J, Sassine D, Liu Y, Grisham RN, Tew WP, Gardner GJ, Zivanovic O, Sonoda Y, Long Roche K, Chi DS, Abu-Rustum NR, Soff GA, Jewell EL. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Gynecol Oncol. 2021 Oct;163(1):36-40. doi: 10.1016/j.ygyno.2021.07.030. Epub 2021 Jul 24. PMID: 34312001; PMCID: PMC8511112.
Copy Download .nbib Format: NLM
Tardigrades exhibit robust interlimb coordination across walking speeds and terrains.

Proceedings of the National Academy of Sciences of the United States of America

Nirody JA, Duran LA, Johnston D, Cohen DJ.
PMID: 34446560
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35). doi: 10.1073/pnas.2107289118.

Tardigrades must negotiate heterogeneous, fluctuating environments and accordingly utilize locomotive strategies capable of dealing with variable terrain. We analyze the kinematics and interleg coordination of freely walking tardigrades (species:

Cite
Nirody JA, Duran LA, Johnston D, et al. Tardigrades exhibit robust interlimb coordination across walking speeds and terrains. Proc Natl Acad Sci U S A. 2021;118(35)doi: 10.1073/pnas.2107289118.
Nirody, J. A., Duran, L. A., Johnston, D., & Cohen, D. J. (2021). Tardigrades exhibit robust interlimb coordination across walking speeds and terrains. Proceedings of the National Academy of Sciences of the United States of America, 118(35), . https://doi.org/10.1073/pnas.2107289118
Nirody, Jasmine A, et al. "Tardigrades exhibit robust interlimb coordination across walking speeds and terrains." Proceedings of the National Academy of Sciences of the United States of America vol. 118,35 (2021). doi: https://doi.org/10.1073/pnas.2107289118
Nirody JA, Duran LA, Johnston D, Cohen DJ. Tardigrades exhibit robust interlimb coordination across walking speeds and terrains. Proc Natl Acad Sci U S A. 2021 Aug 31;118(35). doi: 10.1073/pnas.2107289118. PMID: 34446560; PMCID: PMC8536314.
Copy Download .nbib Format: NLM
Mobilizing Breast Cancer Prevention Research Through Smartphone Apps: A Systematic Review of the Literature.

Frontiers in public health

Houghton LC, Howland RE, McDonald JA.
PMID: 31781525
Front Public Health. 2019 Nov 06;7:298. doi: 10.3389/fpubh.2019.00298. eCollection 2019.

No abstract available.

Cite
Houghton LC, Howland RE, McDonald JA. Mobilizing Breast Cancer Prevention Research Through Smartphone Apps: A Systematic Review of the Literature. Front Public Health. 2019;7:298doi: 10.3389/fpubh.2019.00298.
Houghton, L. C., Howland, R. E., & McDonald, J. A. (2019). Mobilizing Breast Cancer Prevention Research Through Smartphone Apps: A Systematic Review of the Literature. Frontiers in public health, 7298. https://doi.org/10.3389/fpubh.2019.00298
Houghton, Lauren C, et al. "Mobilizing Breast Cancer Prevention Research Through Smartphone Apps: A Systematic Review of the Literature." Frontiers in public health vol. 7 (2019): 298. doi: https://doi.org/10.3389/fpubh.2019.00298
Houghton LC, Howland RE, McDonald JA. Mobilizing Breast Cancer Prevention Research Through Smartphone Apps: A Systematic Review of the Literature. Front Public Health. 2019 Nov 06;7:298. doi: 10.3389/fpubh.2019.00298. eCollection 2019. PMID: 31781525; PMCID: PMC6851054.
Copy Download .nbib Format: NLM
A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine.

medRxiv : the preprint server for health sciences

Salvatore M, Gu T, Mack JA, Sankar SP, Patil S, Valley TS, Singh K, Nallamothu BK, Kheterpal S, Lisabeth L, Fritsche LG, Mukherjee B.
PMID: 32793923
medRxiv. 2021 Feb 20; doi: 10.1101/2020.06.29.20141564.

BACKGROUND: We perform a phenome-wide scan to identify pre-existing conditions related to COVID-19 susceptibility and prognosis across the medical phenome and how they vary by race.METHODS: The study is comprised of 53,853 patients who were tested/positive for COVID-19 between...

Cite
Salvatore M, Gu T, Mack JA, et al. A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine. medRxiv. 2021;doi: 10.1101/2020.06.29.20141564.
Salvatore, M., Gu, T., Mack, J. A., Sankar, S. P., Patil, S., Valley, T. S., Singh, K., Nallamothu, B. K., Kheterpal, S., Lisabeth, L., Fritsche, L. G., & Mukherjee, B. (2021). A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.06.29.20141564
Salvatore, Maxwell, et al. "A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2020.06.29.20141564
Salvatore M, Gu T, Mack JA, Sankar SP, Patil S, Valley TS, Singh K, Nallamothu BK, Kheterpal S, Lisabeth L, Fritsche LG, Mukherjee B. A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine. medRxiv. 2021 Feb 20; doi: 10.1101/2020.06.29.20141564. PMID: 32793923; PMCID: PMC7418740.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 274 entries